Hot Features
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid t... CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0015 | 16.6666666667 | 0.009 | 0.012 | 0.009 | 425883 | 0.01087577 | CS |
| 4 | -0.0005 | -4.54545454545 | 0.011 | 0.0175 | 0.007 | 932691 | 0.01090847 | CS |
| 12 | -0.0195 | -65 | 0.03 | 0.0399 | 0.007 | 882227 | 0.01897331 | CS |
| 26 | -0.0475 | -81.8965517241 | 0.058 | 0.066 | 0.007 | 686874 | 0.02777619 | CS |
| 52 | -0.0595 | -85 | 0.07 | 0.2089 | 0.007 | 737540 | 0.04828731 | CS |
| 156 | -0.0595 | -85 | 0.07 | 0.2089 | 0.007 | 737540 | 0.04828731 | CS |
| 260 | -0.0595 | -85 | 0.07 | 0.2089 | 0.007 | 737540 | 0.04828731 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.